These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15592495)

  • 1. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.
    Nakamura M; Ishida E; Shimada K; Kishi M; Nakase H; Sakaki T; Konishi N
    Lab Invest; 2005 Feb; 85(2):165-75. PubMed ID: 15592495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade.
    Ino Y; Silver JS; Blazejewski L; Nishikawa R; Matsutani M; von Deimling A; Louis DN
    J Neuropathol Exp Neurol; 1999 Aug; 58(8):881-5. PubMed ID: 10446812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 22q allelic losses at microsatellite loci in human astrocytic tumors.
    Muhammad AK; Yoshimine T; Maruno M; Tokiyoshi K; Takemoto O; Hayakawa T
    Neurol Med Chir (Tokyo); 1997 Aug; 37(8):606-10; discussion 611. PubMed ID: 9301196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
    Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
    Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p14ARF deletion and methylation in genetic pathways to glioblastomas.
    Nakamura M; Watanabe T; Klangby U; Asker C; Wiman K; Yonekawa Y; Kleihues P; Ohgaki H
    Brain Pathol; 2001 Apr; 11(2):159-68. PubMed ID: 11303791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression.
    Oskam NT; Bijleveld EH; Hulsebos TJ
    Int J Cancer; 2000 Feb; 85(3):336-9. PubMed ID: 10652423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.
    Nakamura M; Ishida E; Shimada K; Nakase H; Sakaki T; Konishi N
    Acta Neuropathol; 2005 Oct; 110(4):402-10. PubMed ID: 16155764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma.
    Hartmann C; NĂ¼mann A; Mueller W; Holtkamp N; Simon M; von Deimling A
    Int J Cancer; 2004 Mar; 108(6):839-44. PubMed ID: 14712485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity on chromosome 19 in secondary glioblastomas.
    Nakamura M; Yang F; Fujisawa H; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 2000 Jun; 59(6):539-43. PubMed ID: 10850866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
    Tepel M; Roerig P; Wolter M; Gutmann DH; Perry A; Reifenberger G; Riemenschneider MJ
    Int J Cancer; 2008 Nov; 123(9):2080-6. PubMed ID: 18709645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.
    Fujisawa H; Reis RM; Nakamura M; Colella S; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 2000 Jan; 80(1):65-72. PubMed ID: 10653004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of multiple genes in astrocytic gliomas.
    Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
    Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
    Ohgaki H; Kleihues P
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):479-89. PubMed ID: 15977639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas.
    Fleischer M; Kessler R; Klammer A; Warnke JP; Eschrich K
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1010-20. PubMed ID: 21987444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity of microsatellite loci on chromosome 9p in astrocytic tumors and its prognostic implications.
    Maruno M; Yoshimine T; Muhammad AK; Tokiyoshi K; Hayakawa T
    J Neurooncol; 1996 Oct; 30(1):19-24. PubMed ID: 8864999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
    Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.